Metastasis-associated gene signature in primary myxoid liposarcoma identified through a gene expression study

DOI Web Site 参考文献30件
  • Qiao Zhiwei
    Division of Rare Cancer Research, National Cancer Center Research Institute
  • Tajima Takashi
    Division of Rare Cancer Research, National Cancer Center Research Institute Department of Orthpaedic Surgery, Kyorin University. School of Medicine
  • Kito Fusako
    Division of Rare Cancer Research, National Cancer Center Research Institute Department of Innovative Seeds Evaluation, National Cancer Center Research Institute
  • Arai Yasuhito
    Division of Cancer Genomics, National Cancer Center Research Institute
  • Kawai Akira
    Division of Musculoskeletal Oncology, National Cancer Center Hospital
  • Kondo Tadashi
    Division of Rare Cancer Research, National Cancer Center Research Institute Department of Innovative Seeds Evaluation, National Cancer Center Research Institute

抄録

<p>Myxoid liposarcoma (MLS) is a rare mesenchymal malignancy with unique extrapulmonary metastatic potential. Although MLS has been associated with specific chromosomal translocations, the factors and pathways regulating metastasis in MLS remain unknown. To identify the molecular mechanisms underlying MLS metastasis, we compared global gene expression profiles of primary tumor tissues from MLS patients with different metastatic statuses using DNA microarray analysis. In total, 393 genes were differentially expressed between the tumors from four patients with metastasis and those from 11 patients without metastasis. Differentially expressed genes were functionally annotated based on Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis. Supervised classification based on the 393 genes clearly discriminated samples according to metastatic status. The pathways responsible for metastasis included “focal adhesion,” “pathways in cancer,” “ECM-receptor interaction,” and “tight junction.” The differential expression of alpha-synuclein was confirmed at the protein level; the protein was downregulated in metastatic MLS. Meta-analysis revealed that MLS could be discriminated from the other sarcomas based on the expression of the metastasis-associated genes. The metastasis-associated genes identified in this study are worthwhile further investigation to further our understanding of MLS and are expected to lead to novel clinical applications for MLS.</p>

収録刊行物

参考文献 (30)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ